The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma.
Saved in:
| Title: | The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma. |
|---|---|
| Authors: | Fincham REA; Centre for Tumour Biology, Barts Cancer Institute-a Cancer Research United Kingdom (CRUK) Centre of Excellence, Queen Mary University of London, London, UK.; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Periasamy P; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Meng J; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Wee F; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Stasinos K; Centre for Tumour Biology, Barts Cancer Institute-a Cancer Research United Kingdom (CRUK) Centre of Excellence, Queen Mary University of London, London, UK., Goulart MR; Centre for Tumour Biology, Barts Cancer Institute-a Cancer Research United Kingdom (CRUK) Centre of Excellence, Queen Mary University of London, London, UK., Ye J; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Chong LY; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Au BV; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore.; Centre for Quantitative Medicine, Duke-National University of Singapore (NUS) Medical School, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Kocher HM; Centre for Tumour Biology, Barts Cancer Institute-a Cancer Research United Kingdom (CRUK) Centre of Excellence, Queen Mary University of London, London, UK.; Barts and the London Hepato-Pancreato-Biliary (HPB) Centre, The Royal London Hospital, Barts Health National Health Service Trust, London, UK. |
| Source: | Cancer communications (London, England) [Cancer Commun (Lond)] 2025 Feb; Vol. 45 (2), pp. 172-177. Date of Electronic Publication: 2024 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
